New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 26, 2014
07:39 EDTITMNInterMune downgraded to Market Perform from Outperform at Leerink
Leerink downgraded InterMune citing the playing out of its thesis following yesterday's share rally. Leerink said it still believes in Esbriet's efficacy in idiopathic pulmonary fibrosis and raised its price target for shares to $41 from $20.
News For ITMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ITMN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use